GeneGini enables Academic and Pharmaceutical Researchers to prognose, diagnose and sub-categorise more diseases with better accuracy and sensitivity.

Researchers of genetic diseases have a limited choice of genetic biomarkers to help them understand, diagnose, prognose and treat disease. In addition, many existing biomarkers have limited accuracy and reproducibility.

GeneGini identifies and measures new genetic biomarkers of disease not possible by other screening methods. In addition, GeneGini can simultaneously identify reference genes.

The process, which includes computational identification and experimental validation, is reliable, accurate, and has a potentially superior limit of gene detection than existing methods.

Find out more at 

Click here to review Dr Philip Day’s datasets